Increasing resistance to quinolones: A four-year prospective study of urinary tract infection pathogens

International Journal of General Medicine

Volumn 2, Issue , 2009, Pages 171-175

  Omigie, Orhiosefe ^a   Okoror, Lawrence ^a   Umolu, Patience ^a   Ikuuh, Gladys ^a  

^a AMBROSE ALLI UNIVERSITY   (Nigeria)

Author keywords

Antibiotics; Microorganisms; Resistance; UTI

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; NALIDIXIC ACID; PEFLOXACIN; QUINOLONE DERIVATIVE;

ADULT; AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; DRUG POTENCY; ESCHERICHIA COLI; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MICROORGANISM DETECTION; NONHUMAN; PROTEUS; PSEUDOMONAS AERUGINOSA; SEX DIFFERENCE; STAPHYLOCOCCUS AUREUS; URINALYSIS; URINARY TRACT INFECTION;

EID: 77953461520     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Reid G, Sobel JD. Bacterial adherence in the pathogenesis of urinary tract infection: a review. Rev Infect Dis. 1987;9:470-487.
2. Macleod J, Edward C, Bouchier I. Principles and Practice of Medicine. 15th edition. London, UK: English Language Book Society/Churchill Livingstone; 1984. p. 382-395.
3. Hannan M, Cormican M, Flynn J. A comparison of antimicrobial sensitivities of urinary pathogens for the years 1980 and 1990. Ir J Med Sci. 1993;162:499-501.
4. Cattell WR. Urinary tract infections in adults. Postgrad Med J. 1985;61:907-913.
5. Bohnson RR. Urosepsis. Urol Clin North Am. 1986;13:627-635.
6. Schroeder SA, Krupp JA, Tierney LM, Mephee SJ. Current Medical Diagnosis and Treatment. New York, NY: Appleton and Lange; 1990. p. 622-628.
7. Neild GH. Renal medicine: Urinary tract infection. Africa Health. 2005;27(2):13-18.
8. Oakes RR, Badger R, Grove DI. Comparison of direct and standardized testing of infected urine for antimicrobial susceptibilities by disk diffusion. J Clin Microbiol. 1994;32:40-45.
9. Johnson JR, Tiu FS, Stamm WE. Direct antimicrobial susceptibility testing for acute urinary tract infections in women. J Clin Microbiol. 1995;33:2316-2323.
10. Rubin RH, Tolkoff RNE, Contran RS. Urinary tract infections: pyelonephritis and reflux nephropathy. Pediatrics. 1986;83:1085-1141.
11. Wiswell TE, Smith FR, Bass JW. Decreased incidence of urinary tract infections in circumcised male infants. Pediatrics. 1985;75:901-903.
12. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infections. Infect Dis Clin North Am. 1997;11:551-581.
13. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 1999;281:736-738.
14. Kahlmeter G. The ECO* SENS project: A prospective, multinational, multicentre epidemiology survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens - interim report. J Antimicrob Chemother. 2001;46(Suppl A):15-22.
15. Gupta K. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infection in women: a nationwide analysis. Clin Infect Dis. 2001;33:89-94.
16. Wright SW, Wrenn KD, Haynes M, Haas DW. Prevalence and risk factors for multidrug resistant uropathogens in ED patients. Am J Emerg Med. 2000;18:143-146.
17. Alausa KO, Montefiore D. Bacterial infections, sensitivity patterns, and chemotherapy among hospital patients in tropics. Scand J Infect Dis. 1978;10:295-299.
18. Coker AO, Ijaduola GTA, Odugbemi O. Bacterial isolates from chronic discharging ears of Nigerian Children. East Afr Med J. 1983;60:462-466.
19. Eke PI, Rotimi VO. Resistance of pathogenic bacteria to antibiotics. Afr J Med Sci. 1987;16:1-8.
20. Ozerek AE, Roa GG. Antibiotics Resistance. London, UK: Department of Microbiology, Lewishman University Hospital; 2000.
21. Ronald A. The quinolones and renal infection. Drugs. 1999;58(Suppl 2): 96-98.
22. Talan DA, Stamm WE, Hooton TM, et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial. JAMA. 2000;283:1583-1590.
23. Buchanan RE, Gibbons NE. Bergey's Manual of Determinative Bacteriology. 8th edition. Baltimore, MD: Williams & Wilkins; 1974.
24. Harrigan WF, McCane ME. Laboratory Methods in Microbiology. New York, NY: Academic Press; 1976.
25. Cowan ST, Burrow GI, Feltham RKA, editors. Cowan and Steel's Manual for the Identification of Medical Bacteria. 3rd edition. Cambridge, UK: Cambridge University Press; 1993.
26. Cheesbrough M. Biochemical tests to identify bacteria. In: District Laboratory Practice in Tropical Countries, Part 2. Cambridge, UK: Cambridge University Press; 2000. p. 63-70.
27. Stroke E, Ridway T. Antibiotics susceptibility test. In: Bailey T, Stanley M, editors. Diagnostic Microbiology: A Laboratory Manual, 6th edition. Saint Louis, MO: CV Mosby Company; 1980. p. 31-32.
28. Orenstein R, Wong ES. Urinary tract infections in adults. Am Fam Physician. 1999;59:1225-1234, 1237.
29. Lutters M, Vogt N. Antibiotics duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women. Cochrane Database Syst Rev. 2002;(3):CD001535.
30. Lipsky BA. Urinary tract infections in men: Epidemiology, pathophysiology, diagnosis, and treatment. Ann Intern Med. 1989;110:138-150.